Combination cancer immunotherapy

/Combination cancer immunotherapy
Combination cancer immunotherapy 2019-02-26T13:43:10+00:00

Combination therapies are the key drivers of successful treatment of cancer patients in cancer immunotherapy. Recepton intends to drive the discovery and development of the next generation molecules for combination treatments in immuno-oncology with:

  • A broad spectra of immuno-oncology drug candidates
  • A broad portfolio of active  immune receptors  and cell lines for research applications in drug discovery
  • A set of discovery technologies